Elegen

Developer of a platform for the synthesis of DNA using microfluidic technology

placeSan Carlos, California, United States calendar_todayFounded 2017 groups41 employees language elegenbio.com

Innovation

6 patent families (1 granted) — focus: Chemistry & metallurgy, Operations & transport, Physics & computing; filing pace slowing. Cited 388 times.

YearFilings
20191
20202
20213
20223
20234
20242
20252

Social engagement

Social engagement: 7.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Triatomic.

Investor typeCountShare
Venture capital975%
Other / undisclosed325%

Recent activity

16 Jun 2026
Product launch
ENFINIATM IVT Ready DNA templates
11 Jun 2026
Product launch
GEN II Cell-Free DNA Platform
9 Jun 2026
Event
The Evolution of DNA Production: From Cells to Chemistry
Coming soon